Publications by authors named "Axel Mescheder"

Claim this Profile
L
LP2, the first lanthipeptide GPCR agonist in a human pharmacokinetics and safety study.
Pawel Namsolleck, Alan Richardson, Gert N Moll, Axel Mescheder

Peptides· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II study of oncolytic herpes simplex virus NV1020 in patients with extensively pretreated refractory colorectal cancer metastatic to the liver.
Sunil K Geevarghese, David A Geller, Hans A de Haan, Markus Hörer, Anette E Knoll, Axel Mescheder

Hum Gene Ther· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A herpes oncolytic virus can be delivered via the vasculature to produce biologic changes in human colorectal cancer.
Yuman Fong, Teresa Kim, Amit Bhargava, Larry Schwartz, Karen Brown, Axel Mescheder

Mol Ther· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial.
Silvio Tatti, James M Swinehart, Claus Thielert, Hoda Tawfik, Axel Mescheder

Obstet Gynecol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease.
Klaus R Herrlinger, Thomas Witthoeft, Andreas Raedler, Bernd Bokemeyer, Thomas Krummenerl, Axel Mescheder

Am J Gastroenterol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis